-
公开(公告)号:US10167254B2
公开(公告)日:2019-01-01
申请号:US15584818
申请日:2017-05-02
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: James Aaron Balog , Emily Charlotte Cherney , Weiwei Guo , Audris Huang , Jay A. Markwalder , Steven P. Seitz , Weifang Shan , David K. Williams , Natesan Murugesan , Susheel Jethanand Nara , Saumya Roy , Soodamani Thangavel , Ramesh Kumar Sistla , Srinivas Cheruku , Srinivasan Thangathirupathy , Yadagiri Kanyaboina , Nagalakshmi Pulicharla
IPC: A61K31/17 , C07C275/40 , A61K31/196 , A61K31/277 , A61K31/351 , A61K31/382 , A61K31/397 , A61K31/428 , A61K31/437 , A61K31/445 , A61K31/501 , A61K31/505 , A61K31/506 , A61K31/519 , A61K31/5375 , A61K31/5377 , A61K31/538 , A61K39/395 , C07C229/42 , C07C255/58 , C07D205/04 , C07D211/14 , C07D239/47 , C07D265/36 , C07D277/64 , C07D295/155 , C07D309/04 , C07D335/02 , C07D401/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07D309/14 , C07D407/12 , C07D487/08 , C07D265/30 , C07D207/08 , C07D211/08 , C07D307/22 , C07C255/57 , C07C235/38 , C07C235/56 , C07C233/81 , C07C275/42 , C07D207/12 , C07D239/34 , C07D317/46 , C07D413/14 , C07D471/08 , C07C275/30 , A61K45/06
Abstract: There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
-
公开(公告)号:US09624188B2
公开(公告)日:2017-04-18
申请号:US14775976
申请日:2014-03-12
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: James Aaron Balog , Audris Huang , Bin Chen , Libing Chen , Weifang Shan
IPC: C07D305/06 , A61K31/196 , C07C275/42 , C07D239/42 , C07D241/42 , C07D255/02 , A61K31/337 , A61K31/41 , A61K31/42 , A61K31/498 , A61K31/505 , A61K45/06 , C07D261/14
CPC classification number: C07D305/06 , A61K31/196 , A61K31/337 , A61K31/41 , A61K31/42 , A61K31/498 , A61K31/505 , A61K45/06 , C07C275/42 , C07C2101/14 , C07C2601/14 , C07D239/42 , C07D241/42 , C07D255/02 , C07D261/14
Abstract: There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or autoimmune diseases utilizing the compounds of the invention. Formula (I).
-
公开(公告)号:US20150246930A1
公开(公告)日:2015-09-03
申请号:US14429923
申请日:2013-09-20
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Weifang Shan , Ashvinikumar V. Gavai , James Aaron Balog
IPC: C07D498/04 , A61K45/06 , C07D487/04 , A61K31/553 , A61K31/5513
CPC classification number: C07D498/04 , A61K31/138 , A61K31/337 , A61K31/506 , A61K31/5513 , A61K31/553 , A61K31/555 , A61K31/573 , A61K45/06 , C07D487/04 , C07D487/06 , C07D498/06 , A61K2300/00
Abstract: Disclosed are compounds of Formula (I), wherein: X is O or —NR3; R1 is —CH2CH2CH3, —CH2CF3, —CH2CH2CF3, —CH2CF2CH3, —CH2CH2CH2CF3, —CH2CH2CF2CH3, —CH2CH(CH3)CF3, —CH2CH2CH2F, or CH2(cyclopropyl); R2 is —CH2CH2CH3, —CH2CF3, —CH2CH2CF3, —CH2CF2CH3, —CH2CH2CH2CF3, —CH2CH2CH2F, —CH2CH(CH3)CF3, CH2CH2CF2CH3, —CH2(cyclopropyl), —CH(CH3)(cyclopropyl), phenyl, fluorophenyl, chlorophenyl, trifluorophenyl, methylisoxazolyl, pyridinyl, formula (i), formula (ii), formula (iii), formula (iv) or formula (v); Ring A is phenyl or pyridinyl; and R3, Ra, Rb, Rc, y, and z are defined herein. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer.
Abstract translation: 公开了式(I)的化合物,其中:X是O或-NR 3; R1是-CH2CH2CH3,-CH2CF3,-CH2CH2CF3,-CH2CF2CH3,-CH2CH2CH2CF3,-CH2CH2CF2CH3,-CH2CH(CH3)CF3,-CH2CH2CH2F或CH2(环丙基); R2是-CH2CH2CH3,-CH2CF3,-CH2CH2CF3,-CH2CF2CH3,-CH2CH2CH2CF3,-CH2CH2CH2F,-CH2CH(CH3)CF3,CH2CH2CF2CH3,-CH2(环丙基),-CH(CH3)(环丙基),苯基,氟苯基,氯苯基, 三氟苯基,甲基异恶唑基,吡啶基,式(ⅰ),式(ⅱ),式(ⅲ),式(ⅳ)或式(Ⅴ); 环A是苯基或吡啶基; 并且R 3,R a,R b,R c,y和z在本文中定义。 还公开了使用这些化合物抑制Notch受体的方法,以及包含这些化合物的药物组合物。 这些化合物可用于治疗,预防或减缓各种治疗领域(例如癌症)中疾病或病症的发展。
-
公开(公告)号:US20150218111A1
公开(公告)日:2015-08-06
申请号:US14429941
申请日:2013-09-20
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Ashvinikumar V. Gavai , Weifang Shan , James Aaron Balog , Claude A. Quesnelle , Wen-Ching Han , George V. DeLucca , Daniel O'Malley , Brian E. Fink
IPC: C07D243/24 , C07D413/12 , A61K45/06 , C07D413/14 , C07D401/04 , C07D491/056 , A61K31/5513 , C07D401/12
CPC classification number: C07D243/24 , A61K31/5513 , A61K45/06 , C07D401/04 , C07D401/12 , C07D413/12 , C07D413/14 , C07D491/04 , C07D491/056
Abstract: Disclosed are compounds of Formula (I): wherein: R2 is phenyl, fluorophenyl, chlorophenyl, trifluorophenyl, methylisoxazolyl, or pyridinyl; R3 is H, CH3, CH2(cyclopropyl), pyridinyl, chloropyridinyl, or methoxypyridinyl: and Ra, Rb, y, and z are defined herein. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer.
Abstract translation: 公开了式(I)的化合物:其中:R 2是苯基,氟苯基,氯苯基,三氟苯基,甲基异恶唑基或吡啶基; R 3是H,CH 3,CH 2(环丙基),吡啶基,氯吡啶基或甲氧基吡啶基:和R a,R b,y和z在本文中定义。 还公开了使用这些化合物抑制Notch受体的方法,以及包含这些化合物的药物组合物。 这些化合物可用于治疗,预防或减缓各种治疗领域(例如癌症)中疾病或病症的发展。
-
公开(公告)号:US10399933B2
公开(公告)日:2019-09-03
申请号:US15564153
申请日:2016-04-01
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: James Aaron Balog , Weiwei Guo , Audris Huang , Jay A. Markwalder , Weifang Shan , David K. Williams , Susheel Jethanand Nara , Saumya Roy
IPC: C07D309/14 , C07C275/40 , C07D211/10 , A61K31/17 , A61K31/196 , A61K31/277 , A61K31/351 , A61K31/382 , A61K31/397 , A61K31/428 , A61K31/437 , A61K31/445 , A61K31/501 , A61K31/505 , A61K31/506 , A61K31/519 , A61K31/5375 , A61K31/5377 , A61K31/538 , A61K39/395 , C07C229/42 , C07C255/58 , C07D205/04 , C07D211/14 , C07D239/47 , C07D265/36 , C07D277/64 , C07D295/155 , C07D309/04 , C07D335/02 , C07D401/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07D407/12 , C07D487/08 , C07D265/30 , C07D207/08 , C07D211/08 , C07D307/22 , C07C255/57 , C07C235/38 , C07C235/56 , C07C233/81 , C07C275/42 , C07D207/12 , C07D239/34 , C07D317/46 , C07D413/14 , C07D471/08 , C07C275/30 , A61K45/06
Abstract: There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
-
公开(公告)号:US10399932B2
公开(公告)日:2019-09-03
申请号:US15564146
申请日:2016-04-01
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: James Aaron Balog , Emily Charlotte Cherney , Jay A. Markwalder , Steven P. Seitz , Weifang Shan , David K. Williams , Audris Huang , Susheel Jethanand Nara , Saumya Roy , Soodamani Thangavel , Ramesh Kumar Sistla , Srinivas Cheruku , Srinivasan Thangathirupathy , Yadagiri Kanyaboina , Nagalakshmi Pulicharla
IPC: C07D309/14 , C07D405/12 , C07D413/12 , C07D335/02 , C07D211/10 , C07D265/30 , C07D409/12 , C07C275/40 , A61K31/17 , A61K31/196 , A61K31/277 , A61K31/351 , A61K31/382 , A61K31/397 , A61K31/428 , A61K31/437 , A61K31/445 , A61K31/501 , A61K31/505 , A61K31/506 , A61K31/519 , A61K31/5375 , A61K31/5377 , A61K31/538 , A61K39/395 , C07C229/42 , C07C255/58 , C07D205/04 , C07D211/14 , C07D239/47 , C07D265/36 , C07D277/64 , C07D295/155 , C07D309/04 , C07D401/12 , C07D405/14 , C07D417/12 , C07D471/04 , C07D487/04 , C07D407/12 , C07D487/08 , C07D207/08 , C07D211/08 , C07D307/22 , C07C255/57 , C07C235/38 , C07C235/56 , C07C233/81 , C07C275/42 , C07D207/12 , C07D239/34 , C07D317/46 , C07D413/14 , C07D471/08 , C07C275/30 , A61K45/06
Abstract: There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
-
公开(公告)号:US20160060237A1
公开(公告)日:2016-03-03
申请号:US14775976
申请日:2014-03-12
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: James Aaron Balog , Audris Huang , Bin Chen , Libing Chen , Weifang Shan
IPC: C07D305/06 , A61K31/196 , A61K31/337 , C07D261/14 , A61K31/42 , A61K45/06 , A61K31/41 , C07D241/42 , A61K31/498 , C07D239/42 , A61K31/505 , C07C275/42 , C07D255/02
CPC classification number: C07D305/06 , A61K31/196 , A61K31/337 , A61K31/41 , A61K31/42 , A61K31/498 , A61K31/505 , A61K45/06 , C07C275/42 , C07C2101/14 , C07C2601/14 , C07D239/42 , C07D241/42 , C07D255/02 , C07D261/14
Abstract: There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or autoimmune diseases utilizing the compounds of the invention. Formula (I).
Abstract translation: 公开了调节或抑制吲哚胺2,3-双加氧酶(IDO)的酶活性的化合物,含有所述化合物的药物组合物和治疗增殖性疾病的方法,例如癌症,病毒感染和/或自身免疫疾病,其利用 发明。 式(I)。
-
公开(公告)号:US09249157B2
公开(公告)日:2016-02-02
申请号:US14429923
申请日:2013-09-20
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Weifang Shan , Ashvinikumar V. Gavai , James Aaron Balog
IPC: C07D487/04 , C07D498/04 , A61K31/138 , A61K31/337 , A61K31/506 , A61K31/555 , A61K31/573 , A61K31/5513 , A61K31/553 , A61K45/06
CPC classification number: C07D498/04 , A61K31/138 , A61K31/337 , A61K31/506 , A61K31/5513 , A61K31/553 , A61K31/555 , A61K31/573 , A61K45/06 , C07D487/04 , C07D487/06 , C07D498/06 , A61K2300/00
Abstract: Disclosed are compounds of Formula (I), wherein: X is O or —NR3; R1 is —CH2CH2CH3, —CH2CF3, —CH2CH2CF3, —CH2CF2CH3, —CH2CH2CH2CF3, —CH2CH2CF2CH3, —CH2CH(CH3)CF3, —CH2CH2CH2F, or CH2(cyclopropyl); R2 is —CH2CH2CH3, —CH2CF3, —CH2CH2CF3, —CH2CF2CH3, —CH2CH2CH2CF3, —CH2CH2CH2F, —CH2CH(CH3)CF3, CH2CH2CF2CH3, —CH2(cyclopropyl), —CH(CH3)(cyclopropyl), phenyl, fluorophenyl, chlorophenyl, trifluorophenyl, methylisoxazolyl, pyridinyl, formula (i), formula (ii), formula (iii), formula (iv) or formula (v); Ring A is phenyl or pyridinyl; and R3, Ra, Rb, Rc, y, and z are defined herein. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer.
Abstract translation: 公开了式(I)的化合物,其中:X是O或-NR 3; R1是-CH2CH2CH3,-CH2CF3,-CH2CH2CF3,-CH2CF2CH3,-CH2CH2CH2CF3,-CH2CH2CF2CH3,-CH2CH(CH3)CF3,-CH2CH2CH2F或CH2(环丙基); (CH 2)2,CH 2 CH 2 CH 3,-CH 2(环丙基) 三氟苯基,甲基异恶唑基,吡啶基,式(ⅰ),式(ⅱ),式(ⅲ),式(ⅳ)或式(Ⅴ); 环A是苯基或吡啶基; 并且R 3,R a,R b,R c,y和z在本文中定义。 还公开了使用这些化合物抑制Notch受体的方法,以及包含这些化合物的药物组合物。 这些化合物可用于治疗,预防或减缓各种治疗领域(例如癌症)中疾病或病症的发展。
-
公开(公告)号:US11548870B2
公开(公告)日:2023-01-10
申请号:US16950978
申请日:2020-11-18
Applicant: Bristol-Myers Squibb Company
Inventor: Andrew P. Degnan , Godwin Kwame Kumi , Audris Huang , James Aaron Balog , Ashok Vinayak Purandare , Weifang Shan , Guo Li
IPC: C07D407/14 , C07D401/14 , C07D413/14 , C07D417/14 , C07D487/04 , C07D491/107 , A61K31/4439 , A61P35/00 , C07D405/14 , C07D498/18
Abstract: Disclosed are compounds of Formula (I): or a salt thereof, wherein: Z is CR6R6 or C═O; Ring A is: and R1, R2, R3, R4, R5, m, and n are defined herein. Also disclosed are methods of using such compounds to inhibit Helios protein, and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.
-
公开(公告)号:US11066392B2
公开(公告)日:2021-07-20
申请号:US16612076
申请日:2018-05-10
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: James Aaron Balog , Emily Charlotte Cherney , Liping Zhang , Audris Huang , Weifang Shan , David K. Williams , Xiao Zhu , Weiwei Guo
IPC: A61P35/00 , A61K31/444 , A61K31/4709 , A61K31/4375 , A61K31/497 , A61K31/506 , C07D401/12 , C07D403/12 , C07D471/04 , C07D213/85
Abstract: There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
-
-
-
-
-
-
-
-
-